Placenta-on-chip platforms are microfluidic devices that replicate the complex, selective, and bidirectional barrier between maternal and fetal blood circulation. By culturing human placental cells within microengineered chambers, researchers can study placental transport, waste clearance (e.g., urea), and metabolic responses (e.g., glucose transfer under gestational diabetes) without relying on animal models or invasive fetal tissue